| |
| |
|
| Insider
Information: |
Aselage Steve |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
293,421 |
|
|
Indirect Shares
|
19,500 |
|
|
| Direct
Value |
$6,622,171 |
|
|
|
Indirect Value
|
$117,000 |
|
|
| Total
Shares |
312,921 |
|
|
| Total
Value |
$6,739,171 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
4
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-4.0
|
1.5
|
| Percentage
Gain/Loss : |
 -31.1%
|
 62.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
63,339 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2012-12-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
261,200 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
• – – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
16,000 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP Global Comm Operations |
• – – |
2004-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
30,000 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP Global Comm Operations |
• – – |
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
130,800 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
• – – |
2005-06-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(106,667) |
24,133 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
• – – |
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
31,165 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
• – – |
2009-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
45,916 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Business Officer |
• – – |
2009-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
48,416 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Business Officer |
• – – |
2009-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
50,916 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2010-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,200 |
32,587 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2010-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
35,087 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2010-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
37,587 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,478 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
43,978 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
46,478 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
63,685 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2014-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
361,756 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2015-09-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
368,756 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2016-01-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
305,756 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2016-11-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
57,000 |
248,756 |
0 |
- |
|
| ACER |
Acer Therapeutics Inc |
|
• • – |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,905 |
11,905 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2017-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
240,556 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2017-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,000 |
217,556 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,549 |
221,105 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
245,883 |
0 |
- |
|
169 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
